Market Tracker

12/18 5:16am ET

TG Therapeutics Inc (NASDAQ:TGTX)

16.42
Data as of Dec 17
 -0.36 / -2.15%
Today’s Change
3.53
Today|||52-Week Range
18.88
+321.03%
Year-to-Date

Today’s Trading

Previous close16.78
Today’s open16.50
Day’s range-- - --
Volume1,039,152
Average volume (3 months)566,628
Market cap$737.7M
Dividend yield--
Data as of 12/17/2014

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-52.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+699.98%
P/E ratioNM
Price/Sales650.44
Price/Book14.37

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.10+1.29%
OREXOrexigen Therapeutic...+0.46+7.86%
RGLSRegulus Therapeutics...+0.52+3.48%
ENTAEnanta Pharmaceutica...+1.25+3.04%
Data as of 12/17/2014

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$152.4K
Annual profit (last year)-$20.5M
Net profit margin-13,438.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts